Experiment 1136523
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV BOLUS |
| Organism | Empty organism |
| Citation | MARAL,R: MATHE,G: DANTCHEV,D: DELGADO,M: MACHOVER,D: TAPIERO,H: RIBAUD,P: MISSET,JL: GASTIABURU,J:. (1983). ACLACINOMYCIN A: PRESENT STATUS OF EXPERIMENTAL AND CLINICAL STUDIES.. 9(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS 2ND PHASE II TRIAL,26 PATIENTS WITH AML WERE TREATED IN 10 DAY CYCLES.OF THE 22 EVALUABLE FOR THERAPEUTIC ACTIVITY,9 HAD COMPLETE AND 2 HAD PARTIAL REMISSIONS. ALL PATIENTS HAD SEVERE MYELOSUPPRESSION,WITH 4 DEATHS DURING BONE MARROW APLASIA. DIARRHEA,WITH ONE CASE OF PSEUDOMEMBRANOUS COLITIS OCCURED IN 2 CASES. THERE WERE 2 CASES OF CARDIOTOXICITY. |
| Dose amount | 15.0 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |